EC UHPLC column (analytical), NUCLEODUR PFP, 1.8 µm, 100x2 mm ICP-27N-10X-5 Volume 100 µL Syringe Type

Volume 100 µL Syringe Type Gastight Syringe Series 1700 Termination Fixed Needle (FN) Needle Fixed Needle

Lisinopril dihydrate

Galantamine hydrobromide

1000ug/mL CHLORITE 500mL

Readability: 1 g

EC UHPLC column (analytical), NUCLEODUR PFP, 1.8 µm, 100x2 mm ICP-27N-10X-5 Volume 100 µL Syringe TypeThis hydrophobic phase with pentafluorophenyl propyl modification is based on high purity NUCLEODUR silica gel and gives an alternative selectivity in comparison to classical C18 modifications. Separation mechanism based on four retention mechanisms polar interactions (H bonds), dipole dipole interactions, interactions and hydrophobic interactions. Suitable for LC MS due to low bleeding characteristics. Technical Data Downloads Brand NUCLEODUR Pore